Placental protein 14 (PP14) does not predict endometrial status under hormone replacement therapy

References

• Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynecol. 1977; 4: 31–47
   Google Scholar
• Fantl J. A., Cardozo L., McClish D. K. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet. Gynecol. 1994; 83: 12–18
   PubMed Web of Science ®Google Scholar
• Lindsay R., Hart D. M., Clark D. M. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet. Gynecol. 1984; 63: 759–63
   PubMed Web of Science ®Google Scholar
• Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 1991; 20: 47–63
   PubMed Web of Science ®Google Scholar
• Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med. 1975; 293: 1167–70
   PubMed Web of Science ®Google Scholar
• Smith D. C., Prentice R., Thompson D.J., Herman W. L. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 1975; 293: 1164–7
   PubMed Web of Science ®Google Scholar
• Gambrell R. D., Jr. Prevention of endometrial cancer with progestogens. Maturitas 1986; 8: 159–68
   PubMed Web of Science ®Google Scholar
• Fraser I. S. A review of the role of progestogens in hormonal replacement therapy: influence on bleeding patterns. Maturitas 1986; 8: 113–21
   PubMed Web of Science ®Google Scholar
• Padwick M. L., Pryse-Davies J., Whitehead M. I. A simple method for determining the optimal dose of progestin in postmenopausal women receiving estrogens. N. Engl. J. Med. 1986; 315: 930–4
   PubMed Web of Science ®Google Scholar
• Bell S. C. Secretory endometrial/decidual proteins and their function in early pregnancy. J. Reprod. Fertil. 1988; 36(Suppl)109–25
   Google Scholar
• Bell S. C. Synthesis and secretion of proteins by the endometrium and decidua. Implantation: Biological and Clinical Aspects, M. Chapman, J. G. Grudzinskas, T. Chard. Springer, London 1988
   Google Scholar
• Johnson M. R., Brooks A., Norman-Taylor J. Q., Grudzinskas J. G., Wren M. E., Murugni P., Chard T., Abdalla H. Serum placental protein 14 concentrations in the first trimester of ovum donation pregnancies. Hum. Reprod. 1993; 8: 485–7
   Google Scholar
• Bersinger N. A., Brandenberger A. W., Zakher A., Dreher E., Altermatt H.J., Birkhaeuser M. H. Production of endometrial placental protein 14 (PP14) and prolactin by cultured endometrial explants after collagenase and freeze/thaw treatment, and in response to progesterone. Early Preg. Biol. Med. 1995; 1: 134–40
   PubMedGoogle Scholar
• Haenggi W., Riesen W., Birkhaeuser M. H. Postmenopausal hormone replacement therapy with Tibolone decreases serum lipoprotein(a). Eur. J. Clin. Chem. Clin. Biochem. 1993; 31: 645–50
   PubMedGoogle Scholar
• Haenggi W., Linder H. R., Birkhaeuser M. H., Schneider H. Microscopic findings of the nail-fold capillaries - dependence on menopausal status and hormone replacement therapy. Maturitas 1995; 22: 37–46
   PubMed Web of Science ®Google Scholar
• Bersinger N. A., Brandenberger A. W., Birkhaeuser M. H. Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilisation cycles. Hum. Reprod. 1995; 10: 2149–54
   Google Scholar
• Riittinen L., Närvänen O., Virtanen I., Seppälä M. Monoclonal antibodies against endometrial protein PP14 and their use for purification and radioimmunoassay of PP14. J. Immunol. Meth. 1991; 136: 85–90
   Google Scholar
• Cornier E. The Pipelle: a disposable device for endometrial biopsy. Am. J. Obstet. Gynecol. 1984; 148: 109–10
   PubMed Web of Science ®Google Scholar
• Byrjalsen I., Thormann L., Meinecke B., Riis B.J., Christiansen C. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy. Hum. Reprod. 1992; 7: 1042–7
   PubMed Web of Science ®Google Scholar
• Byrjalsen I., Thormann L., Riis B.J., Christiansen C. Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns. Maturitas 1992; 15: 39–46
   Google Scholar
• Seppälä M., Alfthan H., Vartiainen E., Stenman U. H. The post-menopausal uterus: the effect of hormone replacement therapy on serum levels of secretory endometrial protein PP14/b˜-lactoglobulin homologue. Hum. Reprod. 1987; 2: 741–3
   PubMed Web of Science ®Google Scholar
• Julkunen M., Wahlström T., Seppälä M. Human Fallopian tube contains placental protein 14. Am. J. Obstet. Gynecol. 1986; 154: 1076–9
   PubMed Web of Science ®Google Scholar
• Maguiness S. D., Shrimanker K., Djahanbakhch O., Deeks J. J., Teisner B., Grudzinskas J. G. In-vitro synthesis of total protein and placental protein PP14 by the Fallopian tube mucosa: variation in relation to anatomical site, the ovarian cycle and the menopause. Hum. Reprod. 1993; 8: 678–83
   Google Scholar
• Riittinen L. Serous ovarian cyst fluids contain high levels of endometrial placental protein 14. Tumour Biol 1992; 13: 175–9
   Google Scholar
• Telimaa S., Kauppila A., Rönnberg L., Suikkari A. M., Seppälä M. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Am. J. Obstet. Gynecol. 1989; 161: 866–71
   PubMed Web of Science ®Google Scholar
• Kamarainen M., Riittinen L., Seppälä M., Palotie A., Andersson L. C. Progesterone- associated endometrial protein - a constitutive marker of human erythroid precursors. Blood 1994; 84: 467–73
   PubMed Web of Science ®Google Scholar
• Siddle N. C., Jesinger D. K., Whitehead M. I., Turner P., Lewis B., Prescott P. Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone. Br. J. Obstet. Gynaecol. 1990; 97: 1093–100
   Google Scholar
• Vermorken A. J., Sultan C., Goos C. M. Dydrogesterone has no peripheral (anti)-androgenic properties. In Vivo 1987; 1: 167–71
   Google Scholar
• Greenwood P. A., Jesinger D. K. Dydrogesterone to oppose the 100 mg oestradiol implant. Maturitas 1991; 14: 17–21
   Google Scholar
• Rees M., Leather A., Pryse-Davies J., Collins S. A., Barlow D. H., Studd J. W. A first study to compare two dosages of dydrogesterone in opposing the 50 mg oestradiol implant. Maturitas 1991; 14: 9–15
   Google Scholar
• Siddle N. C., Fraser D., Whitehead M. I., Jesinger D. K., Endacott J., Prescott P., Pryse-Davies J. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone. Br. J. Obstet. Gynaecol. 1990; 97: 1101–7
   PubMedGoogle Scholar
• Lane G., Siddle N. C., Ryder T. A., Pryse-Davies J., King R. J., Whitehead M. Effects of dydrogesterone on the oestrogenized postmenopausal endometrium. Br. J. Obstet. Gynaecol. 1986; 93: 55–62
   Google Scholar
• De Visser J., Coert A., Feenstra H., van der Vies J. Endocrinological studies with (7α, 17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14). Arzneimittel-forschung 1984; 34: 1010–17
   PubMed Web of Science ®Google Scholar
• Benedek Jaszmann L.J. Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women. Maturitas 1987, Suppl. 1: 25–33
   Google Scholar
• Lindsay R., Hart D. M., Kraszewski A. A prospective double-blind trial of synthetic steroid (Org OD 14) for preventing post-menopausal osteoporosis. Br. Med. J. 1980; 280: 1207–9
   PubMed Web of Science ®Google Scholar
• Genazzani A. R., Benedek Jaszmann L.J., Hart D. M., Andolsek L., Kicovic P. M., Tax L. Org OD 14 and the endometrium. Maturitas 1991; 13: 243–51
   PubMed Web of Science ®Google Scholar
• Rymer J., Fogelman I., Chapman M. G. The incidence of vaginal bleeding with tibolone treatment. Br. J. Obstet. Gynaecol. 1994; 101: 53–6
   PubMedGoogle Scholar
• Ren S. G., Braunstein G. D., Cedars M., Gambone J., Judd H. Serum concentrations of two endometrial proteins are not useful for monitoring postmenopausal estrogen/progesterone therapy. Fertil. Steril. 1990; 54: 532–4
   Google Scholar